Table of Content

1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type
1.4.2 Varicella
1.4.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Human Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Human Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Human Vaccine Regions by Sales
2.4.1 Global Top Human Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Human Vaccine Regions by Sales (2022-2027)
2.5 Global Top Human Vaccine Regions by Revenue
2.5.1 Global Top Human Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Human Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Vaccine Sales by Manufacturers
3.1.1 Global Top Human Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Human Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Human Vaccine Sales in 2020
3.2 Global Human Vaccine Revenue by Manufacturers
3.2.1 Global Top Human Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Human Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Human Vaccine Revenue in 2020
3.3 Global Human Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Human Vaccine Sales by Type
4.1.1 Global Human Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Human Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Human Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Human Vaccine Revenue by Type
4.2.1 Global Human Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Human Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Human Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Human Vaccine Price by Type
4.3.1 Global Human Vaccine Price by Type (2016-2021)
4.3.2 Global Human Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Human Vaccine Sales by Application
5.1.1 Global Human Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Human Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Human Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Human Vaccine Revenue by Application
5.2.1 Global Human Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Human Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Human Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Human Vaccine Price by Application
5.3.1 Global Human Vaccine Price by Application (2016-2021)
5.3.2 Global Human Vaccine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Human Vaccine Market Size by Type
6.1.1 North America Human Vaccine Sales by Type (2016-2027)
6.1.2 North America Human Vaccine Revenue by Type (2016-2027)
6.2 North America Human Vaccine Market Size by Application
6.2.1 North America Human Vaccine Sales by Application (2016-2027)
6.2.2 North America Human Vaccine Revenue by Application (2016-2027)
6.3 North America Human Vaccine Market Size by Country
6.3.1 North America Human Vaccine Sales by Country (2016-2027)
6.3.2 North America Human Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Vaccine Market Size by Type
7.1.1 Europe Human Vaccine Sales by Type (2017-2027)
7.1.2 Europe Human Vaccine Revenue by Type (2017-2027)
7.2 Europe Human Vaccine Market Size by Application
7.2.1 Europe Human Vaccine Sales by Application (2017-2027)
7.2.2 Europe Human Vaccine Revenue by Application (2017-2027)
7.3 Europe Human Vaccine Market Size by Country
7.3.1 Europe Human Vaccine Sales by Country (2017-2027)
7.3.2 Europe Human Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Vaccine Market Size by Type
8.1.1 Asia Pacific Human Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Human Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Human Vaccine Market Size by Application
8.2.1 Asia Pacific Human Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Human Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Human Vaccine Market Size by Region
8.3.1 Asia Pacific Human Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Human Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Vaccine Market Size by Type
9.1.1 Latin America Human Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Human Vaccine Revenue by Type (2019-2027)
9.2 Latin America Human Vaccine Market Size by Application
9.2.1 Latin America Human Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Human Vaccine Revenue by Application (2019-2027)
9.3 Latin America Human Vaccine Market Size by Country
9.3.1 Latin America Human Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Human Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Human Vaccine Market Size by Type
6.1.1 Middle East and Africa Human Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Human Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Human Vaccine Market Size by Application
6.2.1 Middle East and Africa Human Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Human Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Human Vaccine Market Size by Country
6.3.1 Middle East and Africa Human Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Human Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 CNBG
11.1.1 CNBG Corporation Information
11.1.2 CNBG Overview
11.1.3 CNBG Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CNBG Human Vaccine Product Description
11.1.5 CNBG Related Developments
11.2 Changsheng Life
11.2.1 Changsheng Life Corporation Information
11.2.2 Changsheng Life Overview
11.2.3 Changsheng Life Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Changsheng Life Human Vaccine Product Description
11.2.5 Changsheng Life Related Developments
11.3 Zhifei
11.3.1 Zhifei Corporation Information
11.3.2 Zhifei Overview
11.3.3 Zhifei Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Zhifei Human Vaccine Product Description
11.3.5 Zhifei Related Developments
11.4 ChengDa Bio
11.4.1 ChengDa Bio Corporation Information
11.4.2 ChengDa Bio Overview
11.4.3 ChengDa Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 ChengDa Bio Human Vaccine Product Description
11.4.5 ChengDa Bio Related Developments
11.5 Kangtai
11.5.1 Kangtai Corporation Information
11.5.2 Kangtai Overview
11.5.3 Kangtai Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Kangtai Human Vaccine Product Description
11.5.5 Kangtai Related Developments
11.6 SINOVAC BIOTECH
11.6.1 SINOVAC BIOTECH Corporation Information
11.6.2 SINOVAC BIOTECH Overview
11.6.3 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 SINOVAC BIOTECH Human Vaccine Product Description
11.6.5 SINOVAC BIOTECH Related Developments
11.7 Hissen
11.7.1 Hissen Corporation Information
11.7.2 Hissen Overview
11.7.3 Hissen Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Hissen Human Vaccine Product Description
11.7.5 Hissen Related Developments
11.8 Walvax Biotechnology
11.8.1 Walvax Biotechnology Corporation Information
11.8.2 Walvax Biotechnology Overview
11.8.3 Walvax Biotechnology Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Walvax Biotechnology Human Vaccine Product Description
11.8.5 Walvax Biotechnology Related Developments
11.9 GSK
11.9.1 GSK Corporation Information
11.9.2 GSK Overview
11.9.3 GSK Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 GSK Human Vaccine Product Description
11.9.5 GSK Related Developments
11.10 SANOFI
11.10.1 SANOFI Corporation Information
11.10.2 SANOFI Overview
11.10.3 SANOFI Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 SANOFI Human Vaccine Product Description
11.10.5 SANOFI Related Developments
11.1 CNBG
11.1.1 CNBG Corporation Information
11.1.2 CNBG Overview
11.1.3 CNBG Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CNBG Human Vaccine Product Description
11.1.5 CNBG Related Developments
11.12 NuoCheng Bio
11.12.1 NuoCheng Bio Corporation Information
11.12.2 NuoCheng Bio Overview
11.12.3 NuoCheng Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 NuoCheng Bio Product Description
11.12.5 NuoCheng Bio Related Developments
11.13 Hualan Bio
11.13.1 Hualan Bio Corporation Information
11.13.2 Hualan Bio Overview
11.13.3 Hualan Bio Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Hualan Bio Product Description
11.13.5 Hualan Bio Related Developments
11.14 Tiantan biological
11.14.1 Tiantan biological Corporation Information
11.14.2 Tiantan biological Overview
11.14.3 Tiantan biological Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Tiantan biological Product Description
11.14.5 Tiantan biological Related Developments
11.15 Changchun Baike
11.15.1 Changchun Baike Corporation Information
11.15.2 Changchun Baike Overview
11.15.3 Changchun Baike Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Changchun Baike Product Description
11.15.5 Changchun Baike Related Developments
11.16 Adimmune
11.16.1 Adimmune Corporation Information
11.16.2 Adimmune Overview
11.16.3 Adimmune Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Adimmune Product Description
11.16.5 Adimmune Related Developments
11.17 Zhongyianke Biotech
11.17.1 Zhongyianke Biotech Corporation Information
11.17.2 Zhongyianke Biotech Overview
11.17.3 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Zhongyianke Biotech Product Description
11.17.5 Zhongyianke Biotech Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Human Vaccine Value Chain Analysis
12.2 Human Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Vaccine Production Mode & Process
12.4 Human Vaccine Sales and Marketing
12.4.1 Human Vaccine Sales Channels
12.4.2 Human Vaccine Distributors
12.5 Human Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Vaccine Industry Trends
13.2 Human Vaccine Market Drivers
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints

14 Key Findings in The Global Human Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Varicella
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Polio
Table 5. Major Manufacturers of Hepatitis A
Table 6. Major Manufacturers of Rabies
Table 7. Major Manufacturers of BCG
Table 8. Major Manufacturers of Hepatitis B
Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 10. Major Manufacturers of Pneumococcal
Table 11. Major Manufacturers of Rota vaccine
Table 12. Global Human Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 13. Global Human Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 14. Global Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 15. Global Human Vaccine Sales Market Share by Region (2016-2021)
Table 16. Global Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 17. Global Human Vaccine Sales Market Share by Region (2022-2027)
Table 18. Global Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 19. Global Human Vaccine Revenue Market Share by Region (2016-2021)
Table 20. Global Human Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 21. Global Human Vaccine Revenue Market Share by Region (2022-2027)
Table 22. Global Human Vaccine Sales by Manufacturers (2016-2021) & (M Doses)
Table 23. Global Human Vaccine Sales Share by Manufacturers (2016-2021)
Table 24. Global Human Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 25. Global Human Vaccine Revenue Share by Manufacturers (2016-2021)
Table 26. Human Vaccine Price by Manufacturers 2016-2021 (USD/Dose)
Table 27. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2020)
Table 29. Human Vaccine Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Human Vaccine Product Offered
Table 31. Date of Manufacturers Enter into Human Vaccine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 34. Global Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 35. Global Human Vaccine Sales Share by Type (2016-2021)
Table 36. Global Human Vaccine Sales Share by Type (2022-2027)
Table 37. Global Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 38. Global Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 39. Global Human Vaccine Revenue Share by Type (2016-2021)
Table 40. Global Human Vaccine Revenue Share by Type (2022-2027)
Table 41. Human Vaccine Price by Type (2016-2021) & (USD/Dose)
Table 42. Global Human Vaccine Price Forecast by Type (2022-2027) & (USD/Dose)
Table 43. Global Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 44. Global Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 45. Global Human Vaccine Sales Share by Application (2016-2021)
Table 46. Global Human Vaccine Sales Share by Application (2022-2027)
Table 47. Global Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 48. Global Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 49. Global Human Vaccine Revenue Share by Application (2016-2021)
Table 50. Global Human Vaccine Revenue Share by Application (2022-2027)
Table 51. Human Vaccine Price by Application (2016-2021) & (USD/Dose)
Table 52. Global Human Vaccine Price Forecast by Application (2022-2027) & (USD/Dose)
Table 53. North America Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 54. North America Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 55. North America Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 56. North America Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 57. North America Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 58. North America Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 59. North America Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 60. North America Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 61. North America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 62. North America Human Vaccine Sales by Country (2022-2027) & (M Doses)
Table 63. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 64. North America Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 65. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 66. Europe Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 67. Europe Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 68. Europe Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 69. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 70. Europe Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 71. Europe Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 72. Europe Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 73. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 74. Europe Human Vaccine Sales by Country (2022-2027) & (M Doses)
Table 75. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 76. Europe Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 77. Asia Pacific Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 78. Asia Pacific Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 79. Asia Pacific Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 80. Asia Pacific Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 81. Asia Pacific Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 82. Asia Pacific Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 83. Asia Pacific Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 84. Asia Pacific Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 85. Asia Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses)
Table 86. Asia Pacific Human Vaccine Sales by Region (2022-2027) & (M Doses)
Table 87. Asia Pacific Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 88. Asia Pacific Human Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 89. Latin America Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 90. Latin America Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 91. Latin America Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 92. Latin America Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 93. Latin America Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 94. Latin America Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 95. Latin America Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 96. Latin America Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 97. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 98. Latin America Human Vaccine Sales by Country (2022-2027) & (M Doses)
Table 99. Latin America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 100. Latin America Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Human Vaccine Sales by Type (2016-2021) & (M Doses)
Table 102. Middle East and Africa Human Vaccine Sales by Type (2022-2027) & (M Doses)
Table 103. Middle East and Africa Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Human Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 105. Middle East and Africa Human Vaccine Sales by Application (2016-2021) & (M Doses)
Table 106. Middle East and Africa Human Vaccine Sales by Application (2022-2027) & (M Doses)
Table 107. Middle East and Africa Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 108. Middle East and Africa Human Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 109. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses)
Table 110. Middle East and Africa Human Vaccine Sales by Country (2022-2027) & (M Doses)
Table 111. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 112. Middle East and Africa Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 113. CNBG Corporation Information
Table 114. CNBG Description and Major Businesses
Table 115. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. CNBG Human Vaccine Product
Table 117. CNBG Recent Developments
Table 118. Changsheng Life Corporation Information
Table 119. Changsheng Life Description and Major Businesses
Table 120. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Changsheng Life Human Vaccine Product
Table 122. Changsheng Life Recent Developments
Table 123. Zhifei Corporation Information
Table 124. Zhifei Description and Major Businesses
Table 125. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Zhifei Human Vaccine Product
Table 127. Zhifei Recent Developments
Table 128. ChengDa Bio Corporation Information
Table 129. ChengDa Bio Description and Major Businesses
Table 130. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. ChengDa Bio Human Vaccine Product
Table 132. ChengDa Bio Recent Developments
Table 133. Kangtai Corporation Information
Table 134. Kangtai Description and Major Businesses
Table 135. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Kangtai Human Vaccine Product
Table 137. Kangtai Recent Developments
Table 138. SINOVAC BIOTECH Corporation Information
Table 139. SINOVAC BIOTECH Description and Major Businesses
Table 140. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. SINOVAC BIOTECH Human Vaccine Product
Table 142. SINOVAC BIOTECH Recent Developments
Table 143. Hissen Corporation Information
Table 144. Hissen Description and Major Businesses
Table 145. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Hissen Human Vaccine Product
Table 147. Hissen Recent Developments
Table 148. Walvax Biotechnology Corporation Information
Table 149. Walvax Biotechnology Description and Major Businesses
Table 150. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Walvax Biotechnology Human Vaccine Product
Table 152. Walvax Biotechnology Recent Developments
Table 153. GSK Corporation Information
Table 154. GSK Description and Major Businesses
Table 155. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 156. GSK Human Vaccine Product
Table 157. GSK Recent Developments
Table 158. SANOFI Corporation Information
Table 159. SANOFI Description and Major Businesses
Table 160. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 161. SANOFI Human Vaccine Product
Table 162. SANOFI Recent Developments
Table 163. Rong An Corporation Information
Table 164. Rong An Description and Major Businesses
Table 165. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 166. Rong An Human Vaccine Product
Table 167. Rong An Recent Developments
Table 168. NuoCheng Bio Corporation Information
Table 169. NuoCheng Bio Description and Major Businesses
Table 170. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 171. NuoCheng Bio Human Vaccine Product
Table 172. NuoCheng Bio Recent Developments
Table 173. Hualan Bio Corporation Information
Table 174. Hualan Bio Description and Major Businesses
Table 175. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 176. Hualan Bio Human Vaccine Product
Table 177. Hualan Bio Recent Developments
Table 178. Tiantan biological Corporation Information
Table 179. Tiantan biological Description and Major Businesses
Table 180. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 181. Tiantan biological Human Vaccine Product
Table 182. Tiantan biological Recent Developments
Table 183. Changchun Baike Corporation Information
Table 184. Changchun Baike Description and Major Businesses
Table 185. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 186. Changchun Baike Human Vaccine Product
Table 187. Changchun Baike Recent Developments
Table 188. Adimmune Corporation Information
Table 189. Adimmune Description and Major Businesses
Table 190. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 191. Adimmune Human Vaccine Product
Table 192. Adimmune Recent Developments
Table 193. Zhongyianke Biotech Corporation Information
Table 194. Zhongyianke Biotech Description and Major Businesses
Table 195. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 196. Zhongyianke Biotech Human Vaccine Product
Table 197. Zhongyianke Biotech Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Human Vaccine Distributors List
Table 201. Human Vaccine Customers List
Table 202. Human Vaccine Market Trends
Table 203. Human Vaccine Market Drivers
Table 204. Human Vaccine Market Challenges
Table 205. Human Vaccine Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Market Share by Type in 2020 & 2027
Figure 3. Varicella Product Picture
Figure 4. Influenza Product Picture
Figure 5. Polio Product Picture
Figure 6. Hepatitis A Product Picture
Figure 7. Rabies Product Picture
Figure 8. BCG Product Picture
Figure 9. Hepatitis B Product Picture
Figure 10. Pertussis, Diphtheria, Tetanus Product Picture
Figure 11. Pneumococcal Product Picture
Figure 12. Rota vaccine Product Picture
Figure 13. Global Human Vaccine Sales Market Share by Application in 2020 & 2027
Figure 14. Adults
Figure 15. Children
Figure 16. Human Vaccine Report Years Considered
Figure 17. Global Human Vaccine Sales 2016-2027 (M Doses)
Figure 18. Global Human Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Human Vaccine Revenue 2016-2027 (US$ Million)
Figure 20. Global Human Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Human Vaccine Sales Market Share by Region (2016-2021)
Figure 22. Global Human Vaccine Sales Market Share by Region (2022-2027)
Figure 23. North America Human Vaccine Sales YoY (2016-2027) & (M Doses)
Figure 24. North America Human Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Human Vaccine Sales YoY (2016-2027) & (M Doses)
Figure 26. Europe Human Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Human Vaccine Sales YoY (2016-2027) & (M Doses)
Figure 28. Asia-Pacific Human Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Human Vaccine Sales YoY (2016-2027) & (M Doses)
Figure 30. Latin America Human Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Human Vaccine Sales YoY (2016-2027) & (M Doses)
Figure 32. Middle East & Africa Human Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Human Vaccine Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Human Vaccine Revenue in 2020
Figure 35. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Human Vaccine Sales Market Share by Type (2016-2027)
Figure 37. Global Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 38. Global Human Vaccine Sales Market Share by Application (2016-2027)
Figure 39. Global Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 40. North America Human Vaccine Sales Market Share by Type (2016-2027)
Figure 41. North America Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 42. North America Human Vaccine Sales Market Share by Application (2016-2027)
Figure 43. North America Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 44. North America Human Vaccine Sales Share by Country (2016-2027)
Figure 45. North America Human Vaccine Revenue Share by Country (2016-2027)
Figure 46. U.S. Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Human Vaccine Sales Market Share by Type (2016-2027)
Figure 49. Europe Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 50. Europe Human Vaccine Sales Market Share by Application (2016-2027)
Figure 51. Europe Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 52. Europe Human Vaccine Sales Share by Country (2016-2027)
Figure 53. Europe Human Vaccine Revenue Share by Country (2016-2027)
Figure 54. Germany Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 55. France Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Human Vaccine Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Human Vaccine Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Human Vaccine Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Human Vaccine Revenue Share by Region (2016-2027)
Figure 65. China Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 68. India Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 70. Taiwan Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 74. Philippines Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Latin America Human Vaccine Sales Market Share by Type (2016-2027)
Figure 76. Latin America Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 77. Latin America Human Vaccine Sales Market Share by Application (2016-2027)
Figure 78. Latin America Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 79. Latin America Human Vaccine Sales Share by Country (2016-2027)
Figure 80. Latin America Human Vaccine Revenue Share by Country (2016-2027)
Figure 81. Mexico Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 82. Brazil Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 83. Argentina Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Human Vaccine Revenue Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Human Vaccine Revenue Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Human Vaccine Sales Share by Country (2016-2027)
Figure 89. Middle East and Africa Human Vaccine Revenue Share by Country (2016-2027)
Figure 90. Turkey Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 91. Saudi Arabia Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 92. U.A.E Human Vaccine Revenue (2016-2027) & (US$ Million)
Figure 93. Human Vaccine Value Chain
Figure 94. Human Vaccine Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed